C
C16 Biosciences
C16 uses microbiology to brew sustainable, conflict-free palm oil to reduce global CO2 emissions
About C16 Biosciences
C16 Biosciences is a pioneering startup focused on creating sustainable, high-performance ingredients for consumer goods. The company operates in the biotechnology sector, specifically targeting the beauty, personal care, home care, and food product markets. By leveraging a proprietary biomanufacturing platform, C16 Biosciences produces ingredients that are not only better performing but also environmentally friendly. This approach addresses the current industry's challenges, such as supply and price volatility and increasing consumer and regulatory demands for sustainable products.
The company's primary clients are leading consumer goods manufacturers who seek to incorporate high-quality, sustainable ingredients into their products. These clients benefit from C16 Biosciences' innovative solutions, which help them meet the growing consumer demand for products that are both effective and eco-friendly.
C16 Biosciences operates on a B2B (business-to-business) model. It generates revenue by selling its biodesigned ingredients to consumer goods manufacturers. These manufacturers then use the ingredients in their products, which are sold to end consumers. By focusing on high-value, high-impact ingredients, C16 Biosciences positions itself as a crucial supplier in the supply chain of major consumer goods companies.
In summary, C16 Biosciences is at the forefront of the movement to decarbonize consumer products. By providing sustainable, high-performance ingredients, the company not only supports the health of the planet but also meets the evolving needs of its clients in the consumer goods industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- New York City, United States
- Employees
- 27
- Open positions
- None listed
- Dealroom signal
- 62.6/100
- Sub-industry
- Innovative Food
- Sector
- Food, Biotechnology, Microbiology, Synthetic Biology, Vegan, Sustainable Development Goals, Palm, Fermentation, Climate Tech, Hard Tech, Alternative Fats and Oils, YC S18
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jan 2024 | $1M | $100M | Elemental Excelerator | ↗ |
| GRANT✓Other financing | Jan 2024 | $3.5M | — | Bill & Melinda Gates Foundation | ↗ |
Growth signals
Latest recorded traffic for C16 Biosciences is 460 monthly website visits, down 88.5% over the last three months. C16 Biosciences's team declined 12.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Y Combinator
Wei Guo
UpHonest Capital
Bill & Melinda Gates Foundation
Series A2 investors entered at this stage
Breakthrough Energy Ventures
Elemental Excelerator
Other known investors18 additional known investors
Ali Tamaseb
Blu1877
Climate Capital
DCVC
Dorm Room Fund
Duro
E12 Ventures
Elemental Impact
For Good Ventures
Investo
Liquid 2 Ventures
Meach Cove Capital
New York Ventures
Pioneer Fund
Sinai Ventures
Soma Capital
Unreasonable Group
Zachary Bogue
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about C16 Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See C16 Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







